Long Yinbo, Li Heyang, Jin Zhibin, Zhang Xiang
Department of Neurosurgery, Cangzhou Central Hospital, Cangzhou City, Hebei Province, 061000, People's Republic of China.
Cancer Manag Res. 2021 Feb 10;13:1215-1223. doi: 10.2147/CMAR.S264613. eCollection 2021.
LncRNA SLC16A1-AS1 has been characterized as a critical player in lung cancer, while its role in glioblastoma (GBM) is unknown. By analyzing the TCGA dataset, we observed the upregulation of SLC16A1-AS1 expression in GBM. Therefore, we aimed to investigate the role of SLC16A1-AS1 in this cancer.
GBM tissues and paired non-tumor tissues were collected from 62 GBM patients through biopsy. RT-qPCR was performed to determine the expression of SLC16A1-AS1 and miR-149. Linear regression was used to analyze their correlations. The relationship between SLC16A1-AS1 and miR-149 was assessed by gain and loss of function experiments. Methylation-specific PCR (MSP) and bisulfite sequencing PCR (BSP) were performed to analyze the methylation status of miR-149. Cell proliferation was evaluated by CCK-8 assay and colony formation experiments in GBM cells.
We found that SLC16A1-AS1 expression was upregulated in GBM tissues, and the upregulated expression of SLC16A1-AS1 predicted poor survival of GBM patients. MiR-149 was downregulated in GBM tissues and inversely correlated with the expression of SLC16A1-AS1. In GBM cells, overexpression of SLC16A1-AS1 downregulated the expression of miR-149 and increased the methylation of miR-149 gene. In cell proliferation and colony formation assay, overexpression of SLC16A1-AS1 reduced the inhibitory effects of miR-149 on GBM cell proliferation.
SLC16A1-AS1 may promote GBM cell proliferation by regulating miR-149 methylation. SLC16A1-AS1 can be considered as a potential diagnostic marker in GBM.
长链非编码RNA SLC16A1-AS1已被证实是肺癌中的关键因子,但其在胶质母细胞瘤(GBM)中的作用尚不清楚。通过分析癌症基因组图谱(TCGA)数据集,我们观察到GBM中SLC16A1-AS1表达上调。因此,我们旨在研究SLC16A1-AS1在这种癌症中的作用。
通过活检从62例GBM患者中收集GBM组织和配对的非肿瘤组织。采用逆转录定量聚合酶链反应(RT-qPCR)检测SLC16A1-AS1和miR-149的表达。用线性回归分析它们的相关性。通过功能获得和缺失实验评估SLC16A1-AS1与miR-149之间的关系。采用甲基化特异性聚合酶链反应(MSP)和亚硫酸氢盐测序聚合酶链反应(BSP)分析miR-149的甲基化状态。通过CCK-8法和集落形成实验评估GBM细胞的增殖情况。
我们发现GBM组织中SLC16A1-AS1表达上调,且SLC16A1-AS1表达上调预示着GBM患者预后不良。GBM组织中miR-149表达下调,且与SLC16A1-AS1的表达呈负相关。在GBM细胞中,SLC16A1-AS1的过表达下调了miR-149的表达,并增加了miR-149基因的甲基化。在细胞增殖和集落形成实验中,SLC16A1-AS1的过表达减弱了miR-149对GBM细胞增殖的抑制作用。
SLC16A1-AS1可能通过调节miR-149甲基化促进GBM细胞增殖。SLC16A1-AS1可被视为GBM的潜在诊断标志物。